propranolol has been researched along with reboxetine in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dolan, RJ; Hawellek, B; Hurlemann, R; Kolsch, H; Madea, B; Maier, W; Matusch, A; Vogeley, K; Wollersen, H | 1 |
| De Martino, B; Dolan, RJ; Strange, BA | 1 |
| Aono, Y; Cools, AR; Koshikawa, N; Mizoguchi, N; Oi, Y; Saigusa, T; Sekino, R; Takada, K; Ueda, K | 1 |
| Connor, TJ; González-Reyes, RE; Griffin, EW; Harkin, A; McNamee, EN; Ryan, KJ; Ryan, KM | 1 |
| Critchley, HD; Harrison, NA; Morgan, R | 1 |
| Duarte, ID; Guzzo, LS; Resende, LC; Romero, TR | 1 |
2 trial(s) available for propranolol and reboxetine
| Article | Year |
|---|---|
Noradrenergic modulation of emotion-induced forgetting and remembering.
Topics: Adrenergic beta-Antagonists; Adrenergic Uptake Inhibitors; Adult; Amnesia, Anterograde; Amnesia, Retrograde; Amygdala; Arousal; Double-Blind Method; Emotions; Female; Humans; Male; Memory, Short-Term; Mental Recall; Morpholines; Norepinephrine; Photic Stimulation; Propranolol; Reboxetine | 2005 |
Noradrenergic neuromodulation of human attention for emotional and neutral stimuli.
Topics: Adrenergic beta-Antagonists; Adrenergic Uptake Inhibitors; Adult; Arousal; Attention; Attentional Blink; Brain; Color Perception; Dose-Response Relationship, Drug; Double-Blind Method; Emotions; Female; Humans; Male; Morpholines; Nadolol; Norepinephrine; Pattern Recognition, Visual; Propranolol; Reboxetine; Semantics | 2008 |
4 other study(ies) available for propranolol and reboxetine
| Article | Year |
|---|---|
The reboxetine-induced increase of accumbal dopamine efflux is inhibited by l-propranolol: a microdialysis study with freely moving rats.
Topics: Adrenergic beta-Antagonists; Adrenergic Uptake Inhibitors; Animals; Dopamine; Dose-Response Relationship, Drug; Male; Microdialysis; Morpholines; Norepinephrine; Nucleus Accumbens; Propranolol; Rats; Rats, Sprague-Dawley; Reboxetine; Receptors, Adrenergic, beta; Time Factors | 2008 |
Noradrenaline acting at central beta-adrenoceptors induces interleukin-10 and suppressor of cytokine signaling-3 expression in rat brain: implications for neurodegeneration.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Adrenergic Uptake Inhibitors; Animals; Brain; Cerebral Cortex; Clenbuterol; Dose-Response Relationship, Drug; Drug Therapy, Combination; Hippocampus; Idazoxan; Injections, Intraperitoneal; Interleukin-10; Interleukin-4; Male; Morpholines; Norepinephrine; Phosphorylation; Propranolol; Rats; Rats, Sprague-Dawley; Reboxetine; Receptors, Adrenergic, beta; Receptors, Adrenergic, beta-2; Signal Transduction; STAT3 Transcription Factor; Suppressor of Cytokine Signaling 3 Protein; Suppressor of Cytokine Signaling Proteins; Transforming Growth Factor beta | 2010 |
From facial mimicry to emotional empathy: a role for norepinephrine?
Topics: Adolescent; Adrenergic Antagonists; Adrenergic Uptake Inhibitors; Adult; Brain; Electromyography; Emotions; Empathy; Facial Expression; Facial Muscles; Female; Humans; Imitative Behavior; Male; Morpholines; Norepinephrine; Propranolol; Reboxetine; Young Adult | 2010 |
CB1 and CB2 cannabinoid receptor agonists induce peripheral antinociception by activation of the endogenous noradrenergic system.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-2 Receptor Antagonists; Adrenergic beta-Antagonists; Adrenergic Uptake Inhibitors; Amides; Analgesics; Animals; Arachidonic Acids; Cannabinoid Receptor Agonists; Dinoprostone; Endocannabinoids; Ethanolamines; Male; Morpholines; Norepinephrine; Pain Measurement; Palmitic Acids; Peripheral Nerves; Polyunsaturated Alkamides; Prazosin; Propranolol; Rats; Rats, Wistar; Reboxetine; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Sympathetic Nervous System; Yohimbine | 2013 |